Concepedia

Jolijn W. Groeneweg

JW

8

Publications

279

Citations

8

H-Index

2014

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

University Medical Center Groningen

University of Groningen

University Medical Center Utrecht

Jolijn W. Groeneweg is an author at Massachusetts General Hospital specializing in cancer research, cell biology, and obstetrics.

ORCID

Top concepts

Publications per year

2014–2021

8

Publications

8

Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

Jolijn W. Groeneweg, Celeste M. DiGloria, Jing Yuan et al. · Frontiers in Oncology · 2014 · 58 citations · Full text

Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup

Joline F. Roze, Glen R. Monroe, Joachim Kutzera et al. · Cancers · 2020 · 48 citations · Full text

Dual HER2 Targeting Impedes Growth of <i>HER2</i> Gene–Amplified Uterine Serous Carcinoma Xenografts

Jolijn W. Groeneweg, Sílvia Hernández, Virginia F. Byron et al. · Clinical Cancer Research · 2014 · 41 citations · Full text

HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant

Whitfield B. Growdon, Jolijn W. Groeneweg, Virginia F. Byron et al. · Gynecologic Oncology · 2015 · 37 citations · Full text

Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer

Leslie Bradford, Alejandro Rauh-Hain, Rachel M. Clark et al. · Gynecologic Oncology · 2014 · 35 citations

, , +8

Rows per page

1–5 of 8